CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I/II Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan (GAX-CI) in Combination in Metastatic Pancreatic Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03535727
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:00.581401+00:00
Published At: 2024-01-08T00:00:00+00:00
Record Updated At: 2024-12-31
Results Posted At: 2024-01-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Adenocarcinoma", "Pancreatic Neoplasms", "Neoplasm, Glandular", "Neoplasms", "Neoplasms Pancreatic", "Digestive System Neoplasm", "Endocrine Gland Neoplasms", "Digestive System Disease", "Pancreatic Diseases", "Endocrine System Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-12-31"
protocolSection.identificationModule.nctId: "NCT03535727"
protocolSection.identificationModule.officialTitle: "A Phase I/II Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan (GAX-CI) in Combination in Metastatic Pancreatic Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2024-01-08"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.